Astra Zeneca
MobiHealthNews talks with AstraZeneca’s chief commercial digital officer about partnerships, COVID-19 and what's next for digital health.
The partners will use a new method of training AI known as transformer neural networks.
The pair talk about the shift from traditional clinical trials based on drug research to digital innovations.
The partnership will be looking to use AliveCor's Kardia-K AI, which is designed to measure a patient's potassium levels.
Yesterday at the Voice of Healthcare Summit at Harvard Medical School, panelists discussed the lure of voice technology, its opportunities and the importance of keeping privacy front and center.
At DTx in Boston representatives of major pharma companies discussed opportunies of working with digital theraputics companies and what they wish the startups knew.